The most effective of these has been a soluble form of CTLA-4 (CTLA-4-Ig; Abatacept), which has been FDA approved to treat RA and may be useful in suppressing other autoimmune diseases [59], [60], [61]. The gene discussed is CTLA4; the disease is autoimmune disease.